Año: 2014
Journal Impact Factor (JIF): 14,496
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | 5/290 | Q1 | T1 | D1 |
| NEUROSCIENCES | SCIE | 7/252 | Q1 | T1 | D1 |
| PSYCHIATRY | SCIE | 1/140 | Q1 | T1 | D1 |
Año: 2017
Journal Citation Indicator (JCI): 3,490
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| BIOCHEMISTRY & MOLECULAR BIOLOGY | 4/306 | Q1 | T1 | D1 | 98,86 |
| NEUROSCIENCES | 5/285 | Q1 | T1 | D1 | 98,42 |
| PSYCHIATRY | 5/243 | Q1 | T1 | D1 | 98,15 |
Año:
2014
CiteScore:
21,100
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cellular and Molecular Neuroscience | 2/81 | Q1 | T1 | D1 |
| General Medicine | 65/3264 | Q1 | T1 | D1 |
| Molecular Biology | 11/352 | Q1 | T1 | D1 |
| Psychiatry and Mental Health | 4/468 | Q1 | T1 | D1 |
SJR año:
2014
Factor de Impacto:
6,937
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cellular and Molecular Neuroscience | 1/85 | Q1 | T1 | D1 |
| Molecular Biology | 16/377 | Q1 | T1 | D1 |
| Psychiatry and Mental Health | 2/508 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| Abbott | - |
| Agencia IDEA | 841318 |
| Alzheimer\'s Association | - |
| Alzheimer\'s Disease Neuroimaging Initiative (ADNI) | - |
| Alzheimer\'s Drug Discovery Foundation | - |
| CIBER de Diabetes y Enfermedades Metabolicas Asociadas | - |
| Corporacion Tecnologica de Andalucia | 08/211 |
| Dana Foundation | - |
| Diabetes Research Laboratory, Biomedical Research Foundation | - |
| Fundacio ACE collaborates with CIBERNED | - |
| Fundacion Alzheimur (Murcia) | - |
| Janssen Alzheimer Immunotherapy Research Development | - |
| Johnson & Johnson Pharmaceutical Research & Development LLC | - |
| Medpace, Inc.; Merck Co., Inc.; Meso Scale Diagnostics, LLC | - |
| Ministerio de Educacion y Ciencia | PCT-010000-2007-18; DEX-580000-2008-4 |
| National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering | - |
| National Institutes of Health Grant | U01 AG024904 |
| NIH | P30 AG010129; K01 AG030514 |
| Novartis Pharmaceuticals Corporation; Pfizer Inc | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Boada, M. | Vall d'Hebron Institut de Recerca; Institut Català de Neurociències Aplicades (Spain) |
| 2 | Antúnez, C. | Hospital Virgen de la Arrixaca (Spain) |
| 3 | Ramírez-Lorca, R. | Sin datos () |
| 4 | Destefano, A. L. | Boston University School of Medicine; Boston University (United States) |
| 5 | González-Pérez, A. | Sin datos () |
| 6 | Gayán, J. | Sin datos () |
| 7 | López-Arrieta, J. | Hospital Universitario La Paz (Spain) |
| 8 | Ikram, M. A. | Erasmus MC; Netherlands Consortium for Healthy Ageing (Netherlands) |
| 9 | Hernández, I. | Institut Català de Neurociències Aplicades (Spain) |
| 10 | Marín, J. | Hospital Virgen de la Arrixaca (Spain) |
| 11 | Galán, J. J. | Sin datos () |
| 12 | Bis, J. C. | University of Washington, Seattle (United States) |
| 13 | Mauleón, A. | Institut Català de Neurociències Aplicades (Spain) |
| 14 | Rosende-Roca, M. | Institut Català de Neurociències Aplicades (Spain) |
| 15 | Moreno-Rey, C. | Sin datos () |
| 16 | Gudnasson, V. | Haskoli Islands (Iceland) |
| 17 | Morón, F. J. | Sin datos () |
| 18 | Velasco, J. | Sin datos () |
| 19 | Carrasco, J. M. | Sin datos () |
| 20 | Alegret, M. | Institut Català de Neurociències Aplicades (Spain) |
| 21 | Espinosa, A. | Institut Català de Neurociències Aplicades (Spain) |
| 22 | Vinyes, G. | Institut Català de Neurociències Aplicades (Spain) |
| 23 | Lafuente, A. | Institut Català de Neurociències Aplicades (Spain) |
| 24 | Vargas, L. | Institut Català de Neurociències Aplicades (Spain) |
| 25 | Fitzpatrick, A. L. | University of Washington, Seattle (United States) |
| 26 | Launer, L. J. | National Institute on Aging (United States) |
| 27 | Sáez, M. E. | Sin datos () |
| 28 | Vázquez, E. | Sin datos () |
| 29 | Becker, J. T. | University of Pittsburgh School of Medicine (United States) |
| 30 | López, O. L. | University of Pittsburgh School of Medicine (United States) |
| 31 | Serrano-Ríos, M. | Hospital Clínico San Carlos de Madrid (Spain) |
| 32 | Tárraga, L. | Institut Català de Neurociències Aplicades (Spain) |
| 33 | Van Duijn, C. M. | Erasmus MC; Netherlands Consortium for Healthy Ageing (Netherlands) |
| 34 | Real, L. M. | Sin datos () |
| 35 | Seshadri, S. | Boston University School of Medicine; Boston University; Framingham Heart Study (United States) |
| 36 | Institut Català de Neurociències Aplicades (Spain) |
